Melatonin, a hormone produced by the pineal gland, has unique antioxidant properties that may enhance infertility treatments by mitigating oxidative stress affecting oocyte and embryo quality. Research indicates melatonin supplementation during IVF can improve pregnancy rates and oocyte maturation by lowering reactive oxygen species levels. Its benign safety profile and efficacy in addressing oxidative damage suggest a potential role as an adjunct therapy in infertility treatments.